Email us for help
New York, NY – Emmanuel Joseph Ajala is a biomedical researcher and principal investigator on a relentless quest to resolve some of the scariest diseases of our times, which includes cancer, diabetes, HIV, Ebola, Zika, and especially COVID-19. Some of these quests began when a person near and dear to him was stricken by a particular disorder and he wanted to get to its root cause, such as Frontal Temporal Dementia and Breast Cancer.
Emmanuel was born in Nigeria and came to the US to attend university as his studies advanced. He has a BS in Chemistry and an MS in Chemistry and is a candidate for his PhD. He was also invited, in the middle of his studies, to attend Medical School for Podiatry, and has worked as a professor, surgical technician and research scientist. He is a member of the American Association for the Advancement of Chemistry the American Chemical Society, and the New York Medical Association, and was featured in multiple Who’s Who editions. He has many more years of experience than other researchers; scientific expertise that enabled him to get to where he is today.
He is certainly a scientist in eminent standing, and while employed full time in the daytime, it is the night-time work in his own private company that has the most significance.
One study that Emmanuel Ajala is heavily involved in, is silencing the COVID-19 pathway through a set of glycoproteins derived from the immune system’s dual mitochondrial and endosomal compartments. In plain language, this means he knows that sugar metabolism is chemically related to breaking down the virus, and a potential cure may be a substance close to insulin. He will discuss this in further detail, along with other issues surrounding COVID-19.
In addition, he will discuss his impressive research surrounding the additional issues regarding breast cancer which includes its causes and possible ways to deal with it.